Lexington, MA, United States of America

Nelamangala Nagaraja

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nelamangala Nagaraja: Innovator in Brain Tumor Treatment

Introduction

Nelamangala Nagaraja is a prominent inventor based in Lexington, MA, known for his significant contributions to the field of medical treatments, particularly in the area of brain tumors. With a total of four patents to his name, he has made strides in developing innovative therapies that combine various treatment modalities.

Latest Patents

Nagaraja's latest patents focus on methods of treating brain tumors using combination therapy. These patents provide methods for treating a brain tumor in a patient in need thereof, comprising administering to the patient a compound described in the patents along with radiation therapy and/or one or more additional therapeutic agents. This innovative approach aims to enhance the effectiveness of treatment for patients suffering from brain tumors.

Career Highlights

Throughout his career, Nagaraja has worked with notable companies in the pharmaceutical industry, including Agios Pharmaceuticals, Inc. and Servier Pharmaceuticals LLC. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of his coworkers include Joshua Murtie and Brandon Nicolay, who have played a role in his research endeavors. Their collaboration has further enriched the development of innovative treatment methods.

Conclusion

Nelamangala Nagaraja's work in the field of brain tumor treatment exemplifies the impact of innovation in medicine. His patents and collaborations highlight the importance of combining therapies to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…